z-logo
open-access-imgOpen Access
Glabridin and Anti-Non-Muscle Myosin IIA Therapy Disrupts Non-Small Cell Lung Carcinoma Motility
Author(s) -
Marie KellyWorden,
Amy Troesch,
Sarah Pruitt,
Ryan G. Rhodes,
Deavin Eviston
Publication year - 2021
Publication title -
advances in lung cancer
Language(s) - English
Resource type - Journals
eISSN - 2169-2718
pISSN - 2169-2726
DOI - 10.4236/alc.2021.102002
Subject(s) - myosin , motility , antibody , wound healing , cell migration , pharmacology , combination therapy , cancer cell , chemistry , medicine , cancer research , cancer , cell , microbiology and biotechnology , biochemistry , immunology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here